Bora Pharmaceuticals Co LtdTWSE: 6472

The Company's announcement to the creditor due to the spin off

· Issued by Bora Pharmaceuticals Co Ltd
Close
Today's Information

Provided by: Bora Pharmaceuticals Co., LTD.
SEQ_NO 13 Date of announcement 2022/04/11 Time of announcement 23:42:17
Subject
 The Company's announcement to the creditor due to
the spin off
Date of events 2022/04/11 To which item it meets paragraph 53
Statement
1.Date of occurrence of the event:2022/04/11
2.Company name:Bora Pharmaceuticals Co., LTD.
3.Relationship to the Company (please enter "head office" or
  "subsidiaries"):Head office
4.Reciprocal shareholding ratios:Not applicable
5.Cause of occurrence:To integrate and specialize the Company's
CDMO and dealer business, Bora Pharmaceuticals Co., LTD.'
Board pass the resolution on 2022/04/11 to spin of the
Company's pharmaceuticals department to 100% owned subsidiary
Bora Health Inc. The preliminary reference date of the merger
is set to be 2022/05/31.
6.Countermeasures:To issue material information
7.Any other matters that need to be specified:The company shall
make an announcement to the Company's creditors in accordance
with the local regulations. When the Company's creditors have
any objection to this division, please mail or delivery the proof
of debt in person to 6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd.,
Neihu Dist., Taipei City. When no objection is expressed within
the time limit, it shall mean there is no objection.